Proteome Changes in the Plasma of Myelodysplastic Syndrome Patients with Refractory Anemia with Excess Blasts Subtype 2
Table 1
List of spots that differed significantly when RAEB-2 patients were compared with healthy controls.
Spot
Fold
Protein
Peptides
AC
SC (%)
1
0.0002
−3.8
Serum albumin
20
P02768
56
Fibrinogen alpha chain
2
P02671
3
Hemopexin
2
P02790
20
2
0.008
−3.3
Serum albumin
5
P02768
18
3
0.001
−2.8
Serum albumin
18
P02768
46
Hemopexin
3
P02790
23
4
0.004
−2.7
Plasma protease C1 inhibitor
5
P05155
15
5
0.0001
−2.4
Alpha-2-HS glycoprotein
2
P02765
17
Kininogen-1
3
P01042
7
Corticosteroid-binding globulin
2
P08185
14
6
0.003
−2.4
Serum albumin
5
P02768
13
7
0.007
−2.4
Serum albumin
12
P02768
31
8
0.004
−2.2
Serum albumin
22
P02768
49
9
0.0005
−2.2
Serum albumin
24
P02768
59
10
0.024
2.1
Apolipoprotein A-I
2
P02647
8
C-reactive protein
4
P02741
20
11
0.008
−2.1
Serum albumin
15
P02768
43
Protein Z-dependent protease inhibitor
2
Q9UK55
5
12
0.016
2.1
Unidentified
13
0.017
1.9
Apolipoprotein A-IV
3
P06727
12
Complement factor I
2
P05156
8
14
0.002
−1.9
Inter-alpha-trypsin inhibitor heavy chain H4
5
Q14624
11
15
0.02
1.9
Serum albumin
6
P02768
16
Prothrombin
4
P00734
17
Histidine-rich glycoprotein
2
P04196
4
16
0.001
−1.9
Alpha-2-HS glycoprotein
2
P02765
15
Kininogen-1
2
P01042
4
17
0.011
−1.9
Serum albumin
11
P02768
26
Hemopexin
2
P02790
16
18
0.022
−1.9
Serum albumin
7
P02768
13
19
0.0003
1.8
Leucine-rich alpha-2-glycoprotein
7
P02750
30
Alpha-1-antichymotrypsin
2
P01011
8
20
0.003
1.8
Leucine-rich alpha-2-glycoprotein
5
P02750
28
21
0.039
−1.7
Unidentified
22
0.002
−1.7
Serum albumin
3
P02768
12
23
0.029
1.7
Haptoglobin
4
P00738
18
24
0.004
1.7
Inter-alpha-trypsin inhibitor heavy chain H4
13
Q14624
20
Alpha-1-antitrypsin
7
P01009
37
Angiotensinogen
2
P01019
9
Prothrombin
2
P00734
14
25
0.006
−1.6
Serum albumin
5
P02768
14
26
0.01
−1.6
Unidentified
27
0.027
−1.6
Inter-alpha-trypsin inhibitor heavy chain H4
5
Q14624
6
28
0.011
−1.6
Serum albumin
5
P02768
11
Coagulation factor XII
3
P00748
12
29
0.0008
1.6
Ficolin-2
1
Q15485
4
30
0.02
−1.5
Serum albumin
4
P02768
13
Apolipoprotein A-IV
2
P06727
7
31
0.0006
−1.5
Clusterin
3
P10909
12
32
0.001
−1.5
Unidentified
33
0.004
−1.5
Clusterin
2
P10909
7
34
0.016
−1.5
Beta-2-glycoprotein 1
3
P02749
21
35
0.002
−1.5
Prothrombin
7
P00734
26
Inter-alpha-trypsin inhibitor heavy chain H4
2
Q14624
6
Alpha-1B-glycoprotein
2
P04217
9
36
0.009
−1.4
Tetranectin
4
P05452
37
37
0.002
−1.4
Tetranectin
2
P05452
16
38
0.0002
1.4
Alpha-1-antichymotrypsin
12
P01011
47
Corticosteroid-binding globulin
3
P08185
11
39
0.014
−1.4
Alpha-1-antichymotrypsin
3
P01011
11
Inter-alpha-trypsin inhibitor heavy chain H4
3
Q14624
6
Clusterin
4
P10909
14
40
0.003
−1.4
Clusterin
4
P10909
14
41
0.017
1.4
Alpha-1-antichymotrypsin
2
P01011
8
Zinc-alpha-2 glycoprotein
2
P25311
9
42
0.03
−1.3
Inter-alpha-trypsin inhibitor heavy chain H4
4
Q14624
8
43
0.002
−1.3
Clusterin
4
P10909
15
44
0.027
1.3
Inter-alpha-trypsin inhibitor heavy chain H4
13
Q14624
19
Alpha-1-antitrypsin
3
P01009
18
Complement component C9
2
P02748
6
45
0.012
−1.3
Clusterin
3
P10909
17
Inter-alpha-trypsin inhibitor heavy chain H4
2
Q14624
3
46
0.037
−1.3
Clusterin
4
P10909
17
Inter-alpha-trypsin inhibitor heavy chain H4
3
Q14624
4
47
0.045
1.2
Protein AMBP
2
P02760
12
: ANOVA value; fold: fold difference (multiplication) when comparing RAEB-2 patients and healthy controls (+fold when the normalized volumes increased in RAEB-2); protein: protein identification; peptides: number of unique peptides fulfilling a minimal Mascot score for identity; AC: accession number (SWISS-PROT); SC: protein sequence coverage.